William Mariner Greenman

Title: The Innovations of William Mariner Greenman

Introduction

William Mariner Greenman is a notable inventor based in Lafayette, CA (US). He has made significant contributions to the field of medical therapies, particularly in the area of CAR-T cell therapies. With a total of 2 patents, Greenman continues to push the boundaries of innovation in his field.

Latest Patents

Greenman's latest patents include groundbreaking work on compositions and methods for improved CAR-T cell therapies. This invention focuses on the preparation and use of CAR-T cell-derived effector cells that are modified to limit their proliferation within the recipient. The process involves introducing adducts into the nucleic acids of these cells after in vitro expansion, ensuring that they retain their immunologic function, including the expression of one or more cytokines. Another significant patent addresses methods for inhibiting proliferation of arterial smooth muscle cells. This invention provides methods for preventing restenosis at a site of vascular recanalization through the intravascular administration of a reactive acridine compound, which does not require activation or sustained release.

Career Highlights

Greenman is currently associated with Cerus Corporation, where he applies his expertise to develop innovative medical solutions. His work has been instrumental in advancing therapies that improve patient outcomes in various medical conditions.

Collaborations

Throughout his career, Greenman has collaborated with esteemed colleagues such as John E Hearst and Susan Wollowitz. These partnerships have fostered a collaborative environment that enhances the development of innovative therapies.

Conclusion

William Mariner Greenman exemplifies the spirit of innovation in the medical field. His contributions through patents and collaborations continue to pave the way for advancements in CAR-T cell therapies and vascular treatments.